Evidence-Based Use of IV and IA Thrombolytics in Acute Ischemic Stroke

Jin Moo Lee, M.D., PhD -- Department of Neurology
Washington University School of Medicine -- Presented July 25, 2006
Back Next


References

Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S; for the ATLANTIS Study Investigators
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset: The ATLANTIS Study: A Randomized Controlled Trial.
JAMA. 1999;282:2019-2026
Stroke Trials Directory Entry: ATLANTIS

 

Internet Stroke Center at Washington University:
Copyright © 1997 -2007 All rights reserved.